Advertisement

Topics

CorMedix, Inc.: CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split

16:20 EDT 25 Mar 2019 | FinanzNachrichten

BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 25, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the preventi...

Original Article: CorMedix, Inc.: CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split

NEXT ARTICLE

More From BioPortfolio on "CorMedix, Inc.: CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...